Our first patient GD was found in 1966 to have extensively slow hydroxylation of desmethylimipramine (Fig. 2) . We were able to retrieve this patient 15 years later and to examine her ability to hydroxylate debrisoquine. At the time of this experiment patient GD was the slowest hydroxylator found so far in our screening prog ram. It is of considerable interest to note that this patient originally dropped out from our study because of side-effects at a low dose of DMI and that she during the 15 years had had many prescriptions of psychotropic drugs being oxi dized and often had experienced side-effects at common doses. A similar association between slow hydroxylation and side-effects on nortripty line at low doses has also been reported20). 
